Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 4/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.43 |
| ▸ | HTR1A | P08908 | 3/20 | 0.43 |
| ▸ | GBA1 | P04062 | 3/20 | 0.41 |
| ▸ | TACR1 | P25103 | 3/20 | 0.40 |
| ▸ | REN | P00797 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
| ▸ | UGCG | Q16739 | 2/20 | 0.38 |
| ▸ | GBA2 | Q9HCG7 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3580578 | 0.85 | TACR1 (0.46) | SLC6A2SLC6A4SLC6A3HTR1AGBA1 | |
| SCHEMBL8969997 | 0.80 | GBA1 (0.47) | SLC6A2SLC6A4SLC6A3GBA1HRH1 | |
| SCHEMBL3578666 | 0.79 | SLC6A2 (0.44) | SLC6A2SLC6A4SLC6A3HRH1 | |
| SCHEMBL27526570 | 0.78 | GBA1 (0.45) | SLC6A2SLC6A4SLC6A3GBA1 | |
| SCHEMBL27478385 | 0.77 | DPP4 (0.51) | SLC6A2SLC6A4SLC6A3GBA1HRH1 | |
| SCHEMBL2185547 | 0.74 | GBA1 (0.56) | SLC6A2SLC6A4SLC6A3HTR1AGBA1 | |
| SCHEMBL25308033 | 0.73 | SLC6A2 (0.50) | SLC6A2SLC6A4SLC6A3HTR1AGBA1 | |
| Hydrochloric Acid SCHEMBL26637622 | 0.73 | GBA1 (0.54) | SLC6A2SLC6A4SLC6A3HTR1AGBA1 | |
| SCHEMBL7029186 | 0.72 | GBA1 (0.40) | SLC6A2SLC6A4SLC6A3HTR1AGBA1 | |
| SCHEMBL7982457 | 0.72 | SLC6A2 (0.51) | SLC6A2SLC6A4SLC6A3HTR1AGBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100048549-A1 | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 | Wurster, Siegfried (FI) | 2010-02-25 | — | — | US | disclosed |
| EP-1885693-A1 | PEPTIDOMIMETICS SELECTIVE FOR THE SOMATOSTATIN RECEPTOR SUBTYPES 1 AND/OR 4 | Wurster, Siegfried (FI) | 2008-02-13 | — | — | EP | disclosed |
| WO-2006123020-A1 | PEPTIDOMIMETICS SELECTIVE FOR THE SOMATOSTATIN RECEPTOR SUBTYPES 1 AND/OR 4 | JUVANTIA PHARMA LTD OY (FI) | 2006-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048549-A1 | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 | SSTR1, SSTR4, SSTR3 | SLC6A2 735/4885SLC6A4 151/4885SLC6A3 296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.